Estriol: Targeted Hormone Therapy for Symptom Relief
Estriol
| Product dosage: 1 g | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 1 | 39.78 $ | 39.78 $ (0%) | 🛒 Add to cart |
| 2 | 37.44 $ | 79.56 $ 74.88 $ (6%) | 🛒 Add to cart |
| 3 | 35.49 $ | 119.34 $ 106.47 $ (11%) | 🛒 Add to cart |
| 4 | 34.22 $ | 159.12 $ 136.89 $ (14%) | 🛒 Add to cart |
| 5 | 32.06 $
Best per tube | 198.90 $ 160.29 $ (19%) | 🛒 Add to cart |
Synonyms | |||
Estriol is a bioidentical estrogen hormone primarily indicated for the management of genitourinary syndrome of menopause (GSM), including symptoms such as vaginal dryness, atrophy, and related discomfort. As a weak estrogen, it offers localized efficacy with a favorable safety profile, making it a suitable option for patients seeking relief with minimized systemic absorption. Available in various formulations including creams, suppositories, and tablets, estriol provides targeted action to restore urogenital health and improve quality of life.
Features
- Bioidentical molecular structure identical to endogenous human estriol
- Available in topical, vaginal cream, suppository, and tablet formulations
- Low systemic absorption when used vaginally
- Typically dosed in concentrations ranging from 0.1 mg to 1 mg per application
- Often compounded with other agents like progesterone for balanced therapy
- Prescription-based availability ensuring supervised usage
Benefits
- Effectively alleviates vaginal dryness, itching, and burning associated with menopause
- Restores vaginal epithelial integrity and increases blood flow to urogenital tissues
- Reduces the frequency and severity of urinary tract infections in postmenopausal individuals
- Improves sexual comfort and function by enhancing lubrication and elasticity
- Minimizes systemic estrogenic effects compared to stronger estrogens
- Supports long-term urogenital health with consistent use
Common use
Estriol is most commonly prescribed for the treatment of genitourinary syndrome of menopause, specifically to address symptoms stemming from vaginal atrophy. It is utilized in patients who experience pain during intercourse, recurrent urinary discomfort, or irritation due to estrogen deficiency. Clinicians may also recommend estriol for perioperative preparation in postmenopausal individuals undergoing pelvic surgery to improve tissue quality. Off-label, it is sometimes incorporated into hormone replacement regimens for its tissue-specific effects and mild systemic impact.
Dosage and direction
Dosage varies by formulation and indication. For vaginal cream: typically 0.5 mg applied intravaginally once daily for two weeks, followed by a maintenance dose of 0.5 mg twice weekly. Suppositories: often 0.03 mg to 0.5 mg inserted daily for initial treatment, reducing to twice weekly. Tablets: similar dosing schedule based on provider guidance. Administration should occur at the same time of day to maintain steady levels. Patients are advised to use the applicator provided for accurate dosing and to wash hands before and after application. Treatment duration is individualized; periodic reevaluation by a healthcare provider is recommended.
Precautions
Patients should undergo a thorough medical evaluation prior to initiation, including personal and family history of hormone-sensitive cancers. Annual pelvic exams are advised during treatment. Use with caution in individuals with liver dysfunction, cardiovascular risk factors, or a history of thromboembolic events. Topical application may transfer to others through skin contact; avoid direct contact with partners after application. Discontinue use if allergic reactions occur. Not recommended for use beyond the prescribed duration without reassessment.
Contraindications
Estriol is contraindicated in patients with known hypersensitivity to estriol or any component of the formulation. It should not be used in individuals with undiagnosed abnormal genital bleeding, known or suspected estrogen-dependent neoplasia, active deep vein thrombosis, or pulmonary embolism. Contraindications also include a history of or current arterial thromboembolic disease, liver impairment or disease, and pregnancy or breastfeeding.
Possible side effect
Common side effects may include local irritation, itching, or burning at the application site. Systemic effects are rare but can include headache, breast tenderness, nausea, or abdominal bloating. Some individuals may experience spotting or breakthrough bleeding, particularly during the initial phase of treatment. Less frequently, mood changes, dizziness, or fluid retention may occur. Should any severe or persistent side effects manifest, medical consultation is necessary.
Drug interaction
Estriol may interact with drugs that induce hepatic enzymes, such as rifampicin, carbamazepine, or St. John’s wort, potentially reducing its efficacy. Concurrent use with other estrogenic agents may amplify hormonal effects. Caution is advised with corticosteroids or thyroid medications, as estrogens can influence their metabolism. Anticoagulants like warfarin may have altered effectiveness; monitoring is recommended. Always inform healthcare providers of all concomitant medications, including over-the-counter and herbal products.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to catch up. Consistency is important for optimal results, so patients should strive to adhere to the prescribed regimen. Setting reminders can help maintain regularity.
Overdose
Acute overdose with topical or vaginal estriol is unlikely due to low systemic absorption. However, excessive application may lead to nausea, vomiting, breast discomfort, or withdrawal bleeding. In case of suspected overdose, discontinue use immediately and seek medical attention. Symptomatic and supportive care should be provided; there is no specific antidote. Ensure the product is stored safely to prevent accidental ingestion or misuse.
Storage
Store estriol formulations at room temperature, between 15-30°C (59-86°F), in a dry place away from direct light and moisture. Keep the container tightly closed when not in use. Do not freeze. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Proper disposal of unused medication should follow local guidelines or through a drug take-back program.
Disclaimer
This information is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis, treatment options, and personalized recommendations. Use estriol only as prescribed by a licensed provider. Individual results may vary, and not all uses or risks may be covered here. The manufacturer and publisher are not liable for any adverse outcomes resulting from the use or misuse of this information.
Reviews
Clinical studies and patient reports generally indicate high satisfaction with estriol for relieving GSM symptoms, noting improvement in comfort and quality of life within several weeks of use. Some users mention minimal side effects compared to other estrogen therapies. A minority report initial mild irritation that often resolves with continued use. Overall, it is regarded as an effective and well-tolerated option for localized estrogen therapy under medical supervision.